INS and uterine cancer: The high prevalence of T2D in the 45–49 year age group may be related to an age-related decline in insulin sensitivity; consequently, there is a close interaction between polycystic ovary syndrome (PCOS), uterine cancer, and type 2 diabetes mellitus (30).